27 drugmakers to provide generic COVID drug to low-income countries

Twenty-seven drug makers have signed onto a deal to manufacture a generic version of molnupiravir, Merck’s oral antiviral for the treatment of COVID-19. The deal will allow affordable access to the drug in 105 low- and middle-income countries (LMICs) around the world.